Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    MIRA Pharmaceuticals Inc.

    NASDAQ: MIRA · Real-Time Price · USD
    1.25
    0.04 (3.31%)
    At close: Jun 16, 2025, 3:59 PM
    1.23
    -1.20%
    After-hours: Jun 16, 2025, 05:23 PM EDT

    MIRA Pharmaceuticals Statistics

    Share Statistics

    MIRA Pharmaceuticals has 16.92M shares outstanding. The number of shares has increased by 12.04% in one year.

    Shares Outstanding

    n/a
    		 16.92M

    Shares Change (YoY)

    n/a
    		 12.04%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 7.25%

    Shares Floating

    n/a
    		 12.56M

    Failed to Deliver (FTD) Shares

    n/a
    		 115

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 236.09K, so 1.4% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 236.09K

    Short % of Shares Out

    n/a
    		 1.4%

    Short % of Float

    n/a
    		 1.81%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -2.24 and the forward PE ratio is -3.09. MIRA Pharmaceuticals's PEG ratio is 0.1.

    PE Ratio

    n/a
    		 -2.24

    Forward PE

    n/a
    		 -3.09

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.5

    PB Ratio

    n/a
    		 8

    P/FCF Ratio

    n/a
    		 -3.17

    PEG Ratio

    n/a
    		 0.1
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for MIRA Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.99, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 3.99

    Quick Ratio

    n/a
    		 3.99

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 -48.4

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-3,926,329.5

    Employee Count

    n/a
    		 2

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 73.61% in the last 52 weeks. The beta is 1.98, so MIRA Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.98

    52-Week Price Change

    n/a
    		 73.61%

    50-Day Moving Average

    n/a
    		 1.15

    200-Day Moving Average

    n/a
    		 1.22

    Relative Strength Index (RSI)

    n/a
    		 48.99

    Average Volume (20 Days)

    n/a
    		 1,236,409

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -8.02M

    Net Income

    n/a
    		 -7.85M

    EBITDA

    n/a
    		 -7.85M

    EBIT

    n/a
    		 -7.69M

    Earnings Per Share (EPS)

    n/a
    		 -0.51
    Full Income Statement

    Balance Sheet

    The company has 2.83M in cash and 0 in debt, giving a net cash position of 2.83M.

    Cash & Cash Equivalents

    n/a
    		 2.83M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -29.14M

    Total Assets

    n/a
    		 1.4M

    Working Capital

    n/a
    		 1.26M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -5.56M and capital expenditures 0, giving a free cash flow of -5.56M.

    Operating Cash Flow

    n/a
    		 -5.56M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -5.56M

    FCF Per Share

    n/a
    		 -0.36
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    MIRA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for MIRA is $14, which is 1020% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $14

    Price Target Difference

    n/a
    		 1020%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 80.26

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist